Jed Latkin | Chief Executive Officer, Chief Financial Officer and Chief Operating Officer |
Erika Gibson | Director of Finance and Administration |
Michael Rosol | Chief Medical Officer |
Caroline Palomeque | Maxim Group |
Jacob Notowitz | Private Investor |
Mike Russell | Private Investor |
Joe Ski | Private Investor |
Greetings. And welcome to Navidea Biopharmaceuticals' Fourth Quarter 2018 Earnings Conference Call and Business Update. At this time all participants are in a listen-only-mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded.